Work

In patients with ischemic stroke, NVAF, and ASCVD, adding an antiplatelet to OAC therapy did not affect net clinical benefit at 2 y

Year: 2026

Type: article

Source: Annals of Internal Medicine

DOI: 10.7326/annals-25-05308-jc

Authors: Mukul Sharma, Abhilekh Srivastava

Institution: McMaster University

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7127172248

FWCI:

Cites: 3

Cited by:

Related to: